The short answer
Kava may add to tramadol-related drowsiness and impairment. The exact added risk is unmeasured, but the combination deserves review before use.
What this answer covers
Piper methysticum beverages and extracts; preparations vary.
- Supplement or preparation
- Piper methysticum
- Medication ingredient
- tramadol
The sedating effects can overlap
Tramadol labels warn about serious effects with other CNS depressants. Supplement guidance cautions against combining this herb with sedating substances; that supports a precaution, not a measured pair-specific event rate.
Lack of benefit is not proof of safety
A kava and valerian trial did not establish sleep or anxiety benefit. It did not test tramadol, and its efficacy findings do not exclude additive impairment.
Identify the product and formulation
Kava beverages and concentrated extracts differ. Immediate-release and extended-release tramadol have different directions, and no kava dose or short gap is established as safe.
Review co-use and act on impairment
Discuss the product with the prescriber and avoid driving while impaired. Do not adjust tramadol yourself. Slow breathing or unusual difficulty waking requires emergency help.
Evidence and practical considerations
Side effects & toxicity
Conditional additive-sedation concern from exact tramadol labeling and supplement-specific effects; no exact-pair toxicity magnitude, dose threshold or spacing evidence.
- Exact scope
- Piper methysticum beverages and extracts; preparations vary. with Tramadol10689 IN; oral hydrochloride IR/ER with active M1 and formulation limits.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
Parent tramadol and active M1 metabolite contribute effects; CYP2D6 inhibition can raise parent while lowering M1. Serotonin syndrome, seizures and CNS-depressant risks.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Not interchangeable with extended-release dosing or combination products; no botanical-specific incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed tramadol
CYP3A induction including St John’s wort can alter tramadol exposure; serotonergic and CNS-depressant precautions.
How this applies: Exact tramadol RxCUI 10689 IN, with stated salt/formulation/route bridge.
Once-daily formulation-specific directions and restrictions; not an immediate-release or injectable regimen.
Source 3: federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Kava should not be used with other sedating substances. Various kava products have been linked to rare liver injury, sometimes serious or fatal.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 participants with anxiety and insomnia.
Neither botanical improved its primary anxiety/insomnia outcome over placebo.
How this applies: Original source interpreted for tramadol only within the stated preparation and endpoint limits.
Not a direct tramadol combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact tramadol article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: 4478d43b2dceff88
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.